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Obesity is fast becoming one of the world’s leading health problems and together with its many asso-
ciated medical sequelae signiﬁcantly increases morbidity and mortality. In this review, we brieﬂy explore
the history of bariatric surgery, the beneﬁts of surgery and the various procedures carried out.
 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.Obesity is an abnormal or excessive fat accumulation that may
impair health, and studies suggest that, without intervention,
reversal of obesity is uncommon. The World Health Organization
(WHO) projected that globally, in 2005, at least 400 million adults
were obese and in some countries, including the UK and USA, the
rates of obesity have more than doubled in the past 25 years.
The prevalence of obesity in those over 16 in England is 24%with the
prevalenceofmorbid obesitybeing2.1%. In theUSA, 5.1%of adults are
morbidly obese.1 It is known that the number of people who
are overweight equals the amount who are malnourished across the
planet.2 The relationshipbetweenmorbidobesityandearlymortality
is well recognised. The main adverse health implications of obesity
are associated with type 2 diabetes, hypertension, ischaemic heart
disease, cerebrovascular disease, musculoskeletal disorders such as
osteoarthritis, dyslipidaemia and certain cancers. Moreover, a recent
systematic review found that each 5 point increase in body mass
indexover25wasassociatedwitha30% increase inoverallmortality.3
Other important health sequelae include obstructive sleep apnoea,
infertility, obstetric complications and psychiatric morbidity.
The commonest and most universal method for classifying
obesity is the body mass index (BMI), calculated as body weight in
kilograms divided by height in metres squared (kg/m2). In adults,
a BMI of between 18.5 and 25 is desirable. Overweight is deﬁned as
between 25 and 30 and obesity as a BMI over 30 with severe (or
morbid) obesity being a BMI of more than 40 (see Table 1).
Conservative approaches to managing obesity such as dieting,
exercise and cognitive behavioural therapy produce signiﬁcant
durable weight loss in only a minority of highly motivated patients.
Drugs such as sibutramine and orlistat lead to, at best, modestciates Ltd. Published by Elsevier Ltweight loss and furthermore can only be prescribed for a short
time. Bariatric surgery is the only treatment that produces durable
long-term weight loss.4
1. History of bariatric surgery
The jejunocolic bypass was the original bariatric surgical proce-
dure followed shortly thereafter by the jejunoileal bypass. This
approach was introduced in 1954 and consisted of approximately
35 cmof jejunumanastomosed to around10 cmof ileumas either an
end-to-end or end-to-side anastomosis, which had the effect of
bypassing most of the small intestine. The procedure caused
substantial weight loss but at a cost of unacceptably high compli-
cations which included life-threatening liver failure, renal failure,
immunecomplexdiseaseandnutritional deﬁciencies. It is becauseof
these that the jejunoileal bypass procedure is no longer performed.
In the late 1970s, the gastric bypass was developed and subse-
quently modiﬁed to a Roux-en-Y anastomosis. This procedure was
found to produce equivalent weight loss to the jejunoileal bypass
but with much lower risks of complications.
At present there are 3 broad categories of bariatric procedures:
(i) Pure gastric restriction
(ii) Gastric restriction with some malabsorption (as represented
by the Roux-en-Y gastric bypass)
(iii) Gastric restriction with signiﬁcant intestinal malabsorption
Surgical treatments have the primary aim of promoting the
reduction of the patient’s total volume of ingestion and promoting
total or selective absorptive reduction of the content of food intake,
or both. Surgery is considered to be successful if there is an extra
weight reduction of at least 50% in addition to the maintenance ofd. All rights reserved.
Table 2
Complications of gastric banding.
- Splenic injury
- Oesophageal injury
- Wound infection
- Band slippage
- Band erosion
- Band migration
- Reservoir deﬂation/leak
- Persistent vomiting
- Failure to lose weight
- Acid reﬂux
Table 3
Complications of vertical banded gastroplasty and gastric bypass.
Complications of vertical
banded gastroplasty
Bolus obstruction
Anaemia
Calcium or vitamin deﬁciencies
Leakage
Stenosis
Ulceration
Incisional hernia
Wound infection
Staple line disruption
Pouch dilation
Band erosion
Complications of gastric bypass Anastomotic leak
Acute gastric dilatation
Delayed gastric emptying
Stricture formation causing vomiting
Incisional hernia
Intestinal obstruction
Dumping syndrome
Table 1
Classiﬁcation of obesity based on BMI.
Body mass index (kg/m2) Classiﬁcation
18.5–24.9 Normal
25.0–29.9 Overweight
30.0–34.9 Obesity (type 1)
35.0–39.9 Obesity (type 2)
40.0 Morbid obesity
50.0 Super obesity
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surgical procedure that are in current use.
2. Indications and contraindications for bariatric surgery
The National Institute for Health and Clinical Excellence (NICE)
have published guidelines on the management of adult obesity.5
NICE guidance states that surgical treatment is beneﬁcial for people
with obesity if their BMI is 40, or between 35 and 40 if they have
a coexisting disease which could be improved by weight loss. All
non-surgical treatments should have failed to achieve or maintain
clinically beneﬁcial weight loss for at least 6 months. Surgery can be
considered as ﬁrst-line treatment in patients with a BMI >50. NICE
do not specify an age limit for surgery although general ﬁtness for
surgery will obviously play a major role in the selection of older
patients. In addition to being deemed ﬁt enough for general
anaesthesia, surgery is appropriate only if the patient will receive
specialist management and is committed to long-term follow-up.
Many types of bariatric surgery require long-term supplementation
with vitamins and iron and patients often have a very restricted
liquid diet in the immediate weeks after surgery. Hospital stay is
usually 2–7 days for the majority of procedures.
Contraindications to bariatric surgery include poor myocardial
reserve, signiﬁcant chronic obstructive airways disease or respira-
tory dysfunction, non-compliance with medical treatment and
psychological disorders of a signiﬁcant degree.
3. Bariatric surgical procedures
Bariatric surgery is a major surgical intervention with a risk of
signiﬁcant early and late morbidity and of perioperative mortality.
The most commonly performed procedures are gastric banding,
Roux-en-Y gastric bypass, sleeve gastrectomy and biliopancreatic
diversion. Verical banded gastroplasty (stomach stapling) is rarely,
if ever, performed because of its high long-term failure rate.6
3.1. Gastric banding
Gastric banding, the least invasive of the purely restrictive
procedures, limits food intake by the placement of a constricting
ring completely around the fundus of the stomach. Whilst early
bands were non-adjustable, the modern day bands incorporate an
inﬂatable balloon within their lining to permit adjustment of the
size of the stoma to regulate food intake. Adjustment is undertaken
without the need for surgery by adding or removing saline via
a subcutaneous port. As a restrictive procedure, gastric banding
avoids the problems associated with malabsorptive techniques and
moreover, it is a reversible procedure. It does, as with any surgical
intervention, have potential complications which may require
revision or band removal (see Table 2).
3.2. Gastric bypass
The Roux-en-Y and resectional gastric bypass procedures
combine restriction andmalabsorption techniques, creating a smallgastric pouch and a bypass that prevents the patient from
absorbing all they have eaten. The Roux-en-Y procedure entails
division of the upper stomach to create a small pouch (up to 50 ml)
with a small outlet (gastroenterostomy stoma) to the intestine that
is attached to the pouch. This technique is used to avoid loop gas-
troenterostomy and bile reﬂux that may ensue. It is technically
feasible to reverse a gastric bypass (see Table 3).3.3. Biliopancreatic diversion
This is primarily a malabsorptive procedure and involves the
removal of part of the stomach to limit oral intake and thereby
induce weight loss. The gastric pouch created is larger than that of
gastric bypass or the restrictive procedures therefore allowing
larger meals. Patients remain on less restricted diets thanwould be
the case following gastric bypass. Part of the small intestine is
bypassed (the malabsorptie component) by the fashioning of a long
limb Roux-en-Y anastomosis with a short common ‘‘alimentary’’
channel of approximately 50 cm length.
Biliopancreatic diversion is only a partially reversible operation
and furthermore is considered to be a technically demanding
procedure associated with a high rate of perioperative morbidity
and an operative mortality of 2%.3.4. Sleeve gastrectomy
This is generally considered for those patients who are deemed
high risk for bariatric surgery. It is seen as the ﬁrst stage of a two-
part procedure, being followed at a later date by a conversion to
either a gastric bypass or a duodenal switch. However, for many
patients, a satisfactory reduction in weight is obtained with the
sleeve gastrectomy alone.
Table 5
Complications of sleeve gastrectomy.
- Leakage from stomach
- Vomiting from over-eating
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cally to reduce its size to approximately 25%. It leaves the pylorus
intact meaning that gastric function and digestion are unaltered.
After a period of 6–12 months, the stomach may have expanded
and not restrict intake as much and this is when the gastric bypass
can be added if necessary. The sleeve gastrectomy is not reversible.
The operation is relatively quick to carry out which reduces the risk
of complications.3.5. Vertical banded gastroplasty
Rarely used nowadays, vertical banded gastroplasty involves
partitioning of the stomach using staples to create a small segment
at the top of the stomach which is partially separated from the
remainder of the stomach, with only a small gap (stoma) remaining.
In addition, a polypropylene band may be used around the lower
end of the vertical pouch to prevent stretching. This procedure has
the advantage of being a restrictive procedure with no malab-
sorption component or dumping but weight regain is common.
Complications are relatively rare, with a low postoperative
mortality rate (1%). Revision rates requiring further surgical inter-
vention are often high at approximately 30%.4. Beneﬁts of bariatric surgery
The sole aim of bariatric surgery is to induce signiﬁcant weight
loss which in turn reduces obesity-related medical complications.7
Weight loss, and the loss of visceral fat in particular, is associated
with improved insulin sensitivity and glucose disposal, reduced
ﬂux of free fatty acids and reduced levels of interleukin-6 and
tumour necrosis factor-a.8
Loss of visceral fat also reduces intra-abdominal pressure which
leads to improvements in gastro-oesophageal reﬂux disease,
urinary incontinence, hypertension and venous stasis.9 Mechanical
improvements include less weight bearing stresses on joints, better
pulmonary compliance and reduced fat around the neck which has
a relieving effect on sleep apnoea.10
Lowering of systemic hypertension after bariatric surgery are
secondary to ﬂuid and haemodynamical changes and include
dieresis, natriuresis and a reduction in total body water and blood
volume.11
Furthermore, there are signiﬁcant improvements in type 2
diabetes mellitus, cardiac function including obesity-related
cardiomyopathy, lipid proﬁle, obesity-related infections, mobility,
liver disease, asthma, polycystic ovarian syndrome, infertility and
complications of pregnancy.12 Almost all patients who have had
obesity surgery report vast improvements in both their psychoso-
cial status and quality of life.13Table 4
Complications of biliopancreatic diversion.
- Loose stools
- Stomal ulceration
- Offensive body odour
- Foul smelling stools and ﬂatus
- Anastomotic leak
- Anastomotic ulceration
- Protein malnutrition
- Hypoalbuminaemia
- Anaemia
- Oedema
- Alopecia
- Lack of energy (asthenia)5. Which procedure?
This depends on the available loco-regional expertise and
experience (surgeon and institution), patient choice and risk
stratiﬁcation. Currently, there is no conclusive evidence to recom-
mend one particular procedure over another.6. Effectiveness of bariatric surgery
Surgery is signiﬁcantly and conclusively more effective at
producing sustainableweight loss andcontrollingcomorbidities than
medical treatment.14 Data from the Swedish Obese Subjects Study
show the beneﬁts of bariatric surgery in moderately and morbidly
obese patients compared with conventional treatment. Further
evidence comes from an Australian prospective randomised study of
gastric banding versus conventional treatment in patients with mild
tomoderateobesity.5At2 years the surgicalgrouphadgreaterweight
loss, with an average of 21.6% of initialweight lost and 87.2% of excess
weight lost, whereas the non-surgical group had a loss of 5.5% of
initial weight and 21.8% of excess Tables 4 and 5 weight.7. Conclusion
Bariatric surgery reduces mortality in patients with a BMI>35.15
Moreover, when the risks of death associated with surgery are
taken into account, patients who have had surgery are still more
likely to be alive 1 year after surgery compared to those who have
been managed conservatively.16 A study of employment practices
found that signiﬁcantly more patients worked after surgery than
worked before (76% vs 58%) and that more patients worked longer
hours than they did before (35.8 h vs 30.1 h). Furthermore, fewer
patients claimed welfare beneﬁts.17
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